In patients with NF1, the onset of a GT is related to biallelic inactivation of the NF1 gene, presumably due to errors during DNA replication in mitosis, that leads to the activation of a cascade of growth factors depending on Ras-Raf/MAPK pathway [20]. This evidence concerns the gene NF1 and Glanzmann thrombasthenia 1.